Literature DB >> 21111780

The burden of hospitalisations for community-acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007).

Ruth Gil-Prieto1, Laura García-García, Alejandro Alvaro-Meca, Cristina Méndez, Ana García, Angel Gil de Miguel.   

Abstract

All hospital discharges and deaths related to CAP and pneumococcal-pneumonia from adults over 50 from 2003 to 2007 in Spain were obtained. Among the 447,670 Pneumonia-all causes discharges 17% were pneumococcal pneumonia. The annual hospitalisation rate was 6.27 and 1.09 cases per 1000, respectively. 75,932 deaths for Pneumonia-all causes and 9062 for pneumococcal-pneumonia were reported. CAP and pneumococcal pneumonia are major causes of morbidity and mortality in Spain, especially in the elderly. Despite current preventive measures, no significant changes in hospitalisation, mortality and case-fatality rates were found over the study period. Future preventive measures, like vaccination, could overcome these limitations. Copyright Â
© 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21111780     DOI: 10.1016/j.vaccine.2010.11.025

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  13 in total

1.  Risk of hospitalization due to pneumococcal disease in adults in Spain. The CORIENNE study.

Authors:  Ruth Gil-Prieto; Raquel Pascual-Garcia; Stefan Walter; Alejandro Álvaro-Meca; Ángel Gil-De-Miguel
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

2.  Routine infant vaccination of pneumococcal conjugate vaccines has decreased pneumonia across all age groups in Northern Spain.

Authors:  I Rivero-Calle; J Pardo Seco; P F Raguindin; F Alvez; J Gómez-Rial; A Salas; J Martinón Sanchez; F Martinón-Torres
Journal:  Hum Vaccin Immunother       Date:  2019-12-18       Impact factor: 3.452

3.  Changes in the pneumococcal disease-related hospitalisations in Spain after the replacement of 7-valent by 13-valent conjugate vaccine.

Authors:  L Georgalis; A Mozalevskis; M V Martínez de Aragón; M Garrido-Estepa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-14       Impact factor: 3.267

4.  Impact of routine PCV7 (Prevenar) vaccination of infants on the clinical and economic burden of pneumococcal disease in Malaysia.

Authors:  Syed Aljunid; Gulifeiya Abuduxike; Zafar Ahmed; Saperi Sulong; Amrizal Muhd Nur; Adrian Goh
Journal:  BMC Infect Dis       Date:  2011-09-21       Impact factor: 3.090

5.  Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis.

Authors:  Adoración Navarro-Torné; Eva Agostina Montuori; Vasiliki Kossyvaki; Cristina Méndez
Journal:  Hum Vaccin Immunother       Date:  2021-06-09       Impact factor: 4.526

6.  Passive smoking at home is a risk factor for community-acquired pneumonia in older adults: a population-based case-control study.

Authors:  Jordi Almirall; Mateu Serra-Prat; Ignasi Bolíbar; Elisabet Palomera; Jordi Roig; Imma Hospital; Eugenia Carandell; Mercè Agustí; Pilar Ayuso; Andreu Estela; Antoni Torres
Journal:  BMJ Open       Date:  2014-06-13       Impact factor: 2.692

Review 7.  Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?

Authors:  A Torres; P Bonanni; W Hryniewicz; M Moutschen; R R Reinert; T Welte
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-23       Impact factor: 3.267

8.  Incidence and risk factor prevalence of community-acquired pneumonia in adults in primary care in Spain (NEUMO-ES-RISK project).

Authors:  I Rivero-Calle; J Pardo-Seco; P Aldaz; D A Vargas; E Mascarós; E Redondo; J L Díaz-Maroto; M Linares-Rufo; M J Fierro-Alacio; A Gil; J Molina; D Ocaña; Federico Martinón-Torres
Journal:  BMC Infect Dis       Date:  2016-11-07       Impact factor: 3.090

9.  Budget impact analysis of a pneumococcal vaccination programme in the 65-year-old Spanish cohort using a dynamic model.

Authors:  Roberto Pradas; Angel Gil de Miguel; Alejandro Álvaro; Ruth Gil-Prieto; Reyes Lorente; Cristina Méndez; Pablo Guijarro; Fernando Antoñanzas
Journal:  BMC Infect Dis       Date:  2013-04-11       Impact factor: 3.090

10.  Cost Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccination Program in Chronic Obstructive Pulmonary Disease Patients Aged 50+ Years in Spain.

Authors:  Jose Miguel Rodríguez González-Moro; Rosario Menéndez; Magda Campins; Nadia Lwoff; Itziar Oyagüez; María Echave; Javier Rejas; Fernando Antoñanzas
Journal:  Clin Drug Investig       Date:  2016-01       Impact factor: 2.859

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.